These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10562476)

  • 1. Stent coatings and local drug delivery; state of the art.
    Gunn J; Cumberland D
    Eur Heart J; 1999 Dec; 20(23):1693-700. PubMed ID: 10562476
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation.
    Rossini R; Angiolillo DJ; Musumeci G; Scuri P; Invernizzi P; Bass TA; Mihalcsik L; Gavazzi A
    Am J Cardiol; 2008 Mar; 101(6):786-9. PubMed ID: 18328841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive stent coatings in the drug-eluting era.
    Menown I; Lowe R; Penn I
    J Invasive Cardiol; 2005 Apr; 17(4):222-8. PubMed ID: 15831978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of SafeCut Balloon for treatment of in-stent restenosis of a previously underexpanded sirolimus-eluting stent with a heavily calcified plaque.
    Otsuka Y; Kasahara Y; Kawamura A
    J Invasive Cardiol; 2007 Dec; 19(12):E359-62. PubMed ID: 18180527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradable, drug-eluting stents: a new frontier for the treatment of coronary artery disease.
    Kohn J; Zeltinger J
    Expert Rev Med Devices; 2005 Nov; 2(6):667-71. PubMed ID: 16293093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of endothelial cells in vitro on Paclitaxel-loaded coronary stents.
    Prasad CK; Resmi KR; Krishnan LK; Vaishnav R
    J Biomater Appl; 2005 Apr; 19(4):271-86. PubMed ID: 15788425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymers, drug release, and drug-eluting stents.
    Commandeur S; van Beusekom HM; van der Giessen WJ
    J Interv Cardiol; 2006 Dec; 19(6):500-6. PubMed ID: 17107364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stent after-care: new approaches to coagulation inhibiting therapy].
    Mudra H
    Herz; 1995 Jun; 20(3):221-3. PubMed ID: 7635403
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of heparin-coated stent in early setting of acute myocardial infarction.
    Shin EK; Son JW; Sohn MS; Jin DK; Park GS; Koh KK; Ahn TH; Choi IS
    Catheter Cardiovasc Interv; 2001 Mar; 52(3):306-12. PubMed ID: 11246241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of biodegradable stents.
    Tanguay JF; Zidar JP; Phillips HR; Stack RS
    Cardiol Clin; 1994 Nov; 12(4):699-713. PubMed ID: 7850839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Still a future for the bare metal stent?
    Barlis P; Di Mario C
    Int J Cardiol; 2007 Sep; 121(1):1-3. PubMed ID: 17360051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restenosis of the CYPHER-Select, TAXUS-Express, and Polyzene-F nanocoated cobalt-chromium stents in the minipig coronary artery model.
    Radeleff B; Thierjung H; Stampfl U; Stampfl S; Lopez-Benitez R; Sommer C; Berger I; Richter GM
    Cardiovasc Intervent Radiol; 2008; 31(5):971-80. PubMed ID: 18095019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A stent is not just a stent: Stent construction and design do matter in its clinical performance.
    Lau KW; Johan A; Sigwart U; Hung JS
    Singapore Med J; 2004 Jul; 45(7):305-11; quiz 312. PubMed ID: 15221045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex coronary intervention in the drug-eluting stent era. Introduction.
    Kereiakes DJ
    Rev Cardiovasc Med; 2005; 6 Suppl 1():S1-2. PubMed ID: 15665792
    [No Abstract]   [Full Text] [Related]  

  • 15. [State of treatment of coronary artery disease by drug releasing stents].
    Müller R; Büllesfeld L; Gerckens U; Grube E
    Herz; 2002 Sep; 27(6):508-13. PubMed ID: 12378395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local paclitaxel delivery as a treatment of persistent, recurrent in-stent restenosis -- safety assessment.
    Buszman P; Zurakowski A; Gruszka A; Szkróbka I; Peszek-Przybyła E; Radwan K; Milewski K; Barteczko Z; Tendera M
    Kardiol Pol; 2006 Mar; 64(3):268-72; discussion 273-4. PubMed ID: 16583327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory stent coatings: dexamethasone and related compounds.
    Park SH; Lincoff AM
    Semin Interv Cardiol; 1998; 3(3-4):191-5. PubMed ID: 10406692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of stents in the current era: long-term antiplatelet therapy and late-stent thrombosis.
    Buxton B
    ANZ J Surg; 2008; 78(1-2):2-5. PubMed ID: 18199197
    [No Abstract]   [Full Text] [Related]  

  • 19. Stents in jackets: the latest in endovascular haute couture.
    Heuser RR
    Cathet Cardiovasc Diagn; 1996 Jun; 38(2):179. PubMed ID: 8776523
    [No Abstract]   [Full Text] [Related]  

  • 20. Very late drug-eluting stent thrombosis and cardiogenic shock: 1,249 days after implantation.
    Chen JP
    J Invasive Cardiol; 2007 Dec; 19(12):E381-4. PubMed ID: 18180534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.